Enzo Biochem, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Supplemental disclosure for statement of cash flows

Supplemental disclosure for statement of cash flows	3 Months Ended
Oct. 31, 2014
Supplemental Cash Flow Elements [Abstract]
Cash Flow, Supplemental Disclosures [Text Block]	Note 3 - Supplemental disclosure for statement of cash flows For the three months ended October 31, 2014 and 2013, income taxes paid by the Company were $26 and $5, respectively. For the three months ended October 31, 2014 and 2013, interest paid by the Company was $69 and $62, respectively. For the three months ended October 30, 2014 and 2013, the Company financed $19 and $115 respectively, in machinery and transportation equipment under installment loans. During the three months ended October 31, 2014 and 2013, the Company did not enter into any capital lease agreements. During the three months ended October 31, 2014, the Company recorded $45 in additional paid in capital and reduced accrued liabilities by the same amount for options previously issued in lieu of cash payment of certain incentive compensation awards.

Supplemental disclosure for statement of cash flows

3 Months Ended

Oct. 31, 2014

Supplemental Cash Flow Elements [Abstract]

Cash Flow, Supplemental Disclosures [Text Block]

Note 3 - Supplemental disclosure for statement of cash flows

For the three months ended October 31, 2014 and 2013, income taxes paid by the Company were $26 and $5, respectively.

For the three months ended October 31, 2014 and 2013, interest paid by the Company was $69 and $62, respectively.

For the three months ended October 30, 2014 and 2013, the Company financed $19 and $115 respectively, in machinery and transportation equipment under installment loans.

During the three months ended October 31, 2014 and 2013, the Company did not enter into any capital lease agreements.

During the three months ended October 31, 2014, the Company recorded $45 in additional paid in capital and reduced accrued liabilities by the same amount for options previously issued in lieu of cash payment of certain incentive compensation awards.